Quantamental Technologies’s Bristol-Myers Squibb BMY Stock Holding History

Quantamental Technologies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,395	Closed	-$651K	–	484
2023 Q1	$651K	Sell	9,395 -9,883	-51%	-$697K	0.35%	84
2022 Q4	$1.39M	Buy	+19,278	New	+$1.45M	0.63%	19
2022 Q2	–	Sell	-9,581	Closed	-$700K	–	417
2022 Q1	$700K	Buy	+9,581	New	+$643K	0.4%	77
2021 Q4	–	Sell	-12,841	Closed	-$760K	–	391
2021 Q3	$760K	Buy	12,841 +6,565	+105%	+$432K	0.51%	62
2021 Q2	$419K	Sell	6,276 -6,407	-51%	-$418K	0.37%	101
2021 Q1	$801K	Buy	12,683 +7,660	+152%	+$477K	2.57%	5
2020 Q4	$312K	Buy	+5,023	New	+$309K	0.97%	37
2020 Q2	–	Sell	-5,800	Closed	-$323K	–	279
2020 Q1	$323K	Buy	+5,800	New	+$355K	0.75%	48
2019 Q3	–	Sell	-7,321	Closed	-$332K	–	1540
2019 Q2	$332K	Sell	7,321 -7,226	-50%	-$337K	0.12%	278
2019 Q1	$694K	Buy	+14,547	New	+$725K	0.32%	45

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quantamental Technologies's BMY Position: Q2 2023 in Review

Quantamental Technologies sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 9,395 shares — an estimated $651K sold.

Quantamental Technologies first reported a position in BMY in Q1 2019 and held it in 10 quarters. The position peaked at $1.39M in Q4 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Quantamental Technologies reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Quantamental Technologies sold 9,395 Bristol-Myers Squibb shares in Q2 2023, an estimated $651K.
Quantamental Technologies first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 10 quarters.
Quantamental Technologies's Bristol-Myers Squibb position peaked at $1.39M in Q4 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.